These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1389 related items for PubMed ID: 16135786

  • 1. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 2. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.
    Zhang Y, Liao M, Dufau ML.
    Mol Cell Biol; 2006 Sep; 26(18):6748-61. PubMed ID: 16943418
    [Abstract] [Full Text] [Related]

  • 3. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 4. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.
    Oncogene; 2003 Jul 17; 22(29):4509-16. PubMed ID: 12881707
    [Abstract] [Full Text] [Related]

  • 5. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK, Mitra S.
    Carcinogenesis; 2003 Aug 17; 24(8):1337-45. PubMed ID: 12807730
    [Abstract] [Full Text] [Related]

  • 6. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 7. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
    Ghoshal K, Datta J, Majumder S, Bai S, Dong X, Parthun M, Jacob ST.
    Mol Cell Biol; 2002 Dec 15; 22(23):8302-19. PubMed ID: 12417732
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 11. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116.
    Choi JH, Min NY, Park J, Kim JH, Park SH, Ko YJ, Kang Y, Moon YJ, Rhee S, Ham SW, Park AJ, Lee KH.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):449-54. PubMed ID: 19914212
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylation directs DNA methylation in survivin gene silencing.
    Ma AN, Lu J, Zhou XJ, Wang YX.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):268-72. PubMed ID: 21130077
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
    Krieger S, Grunau C, Sabbah M, Sola B.
    Exp Hematol; 2005 Jun 07; 33(6):652-9. PubMed ID: 15911089
    [Abstract] [Full Text] [Related]

  • 14. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 15. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 20; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM, Soeth E, Smith CL.
    Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222
    [Abstract] [Full Text] [Related]

  • 17. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y, Dufau ML.
    J Biol Chem; 2002 Sep 06; 277(36):33431-8. PubMed ID: 12091390
    [Abstract] [Full Text] [Related]

  • 18. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F, Caby S, Oger F, Cosseau C, Capron M, Grunau C, Dissous C, Pierce RJ.
    Mol Biochem Parasitol; 2009 Nov 12; 168(1):7-15. PubMed ID: 19538992
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.